bioRxivImmunology
Inhibition of infection-induced vascular permeability modulates host leukocyte recruitment to Mycobacterium marinum granulomas in zebrafish
J. Y. Kam, T. Cheng, D. C. Garland, W. J. J. Britton, D. M. Tobin, S. H. Oehlers
Abstract
Mycobacterial granuloma formation involves significant stromal remodeling and the growth of leaky, granuloma-associated vasculature. These permeable blood vessels aid mycobacterial growth, as anti-angiogenic or vascular normalizing therapies are beneficial host-directed therapies in pre-clinical models of tuberculosis. Here we demonstrate that vascular normalization through vascular endothelial-protein tyrosine phosphatase inhibition decreases granuloma hypoxia, the opposite effect of hypoxia-inducing anti-angiogenic therapy. Vascular normalization leads to increased T cell and decreased neutrophil recruitment to granulomas, correlates of a protective immune response against mycobacterial infection.
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Treatment of infection-induced vascular pathologies is protective against persistent rough morphotype Mycobacterium abscessus infection in zebrafish
J. Y. Kam, K. Wright, … S. H. Oehlers·bioRxiv·Nov 23, 2021
- High content analysis of granuloma histology and neutrophilic inflammation in adult zebrafish infected with Mycobacterium marinum
T. Cheng, J. Y. Kam, … S. Oehlers·bioRxiv·Sep 9, 2019
- Macrophage adaptation to hypoxia in the tuberculous granuloma potentiates mycobacterium-induced mitochondrial damage and granuloma necrosis
Antonio J. Pagán, Bingnan Lyu, … Lalita Ramakrishnan·bioRxiv·Feb 7, 2026
- Transient Vascular Occlusions in a Zebrafish Model of Tuberculous Meningitis
Megan I. Hayes, Sumedha Ravishankar, … Cressida A. Madigan·bioRxiv·Feb 28, 2025
- Mycobacterium marinum infection drives foam cell differentiation in zebrafish infection models
M. D. Johansen, J. A. Kasparian, … S. H. Oehlers·bioRxiv·May 10, 2018
- The repurposed STAT3 inhibitor pyrimethamine controls mycobacterial infection-induced vascular permeability and mycobacterial burden
Darryl JY Han, Xiangyu Sui, … Stefan H. Oehlers·Biomedicine & PharmacotherapyPeer-reviewed·Aug 12, 2025